The first indicators of AD are elevated concentrations of amyloid-beta Aβ1–40, tau, and p-tau, and the increasing amyloid-beta Aβ1–40/Aβ1–42 ratio in the CSF [9,10,11]. This evidence concerns the gene MAPT and Alzheimer disease.